Listing #8775440 oncnursingnews.com
351
The FDA granted a priority review for a Biologics License Application (BLA) to
bastilimab for the treatment of recurrent or metastatic cervical cancer. Cancer ...
Category
Website Performance
| cumulativeLayoutShift | 0 Sec |
| observedLoad | 3.44 Sec |
| observedSpeedIndexTs | 3935870551880 |
| observedFirstVisualChange | 0.33 Sec |
| firstMeaningfulPaint | 2.22 Sec |
| observedLargestContentfulPaint | 1.41 Sec |
| observedLargestContentfulPaintAllFrames | 1.41 Sec |
| observedFirstPaintTs | 3935868473010 |
| totalCumulativeLayoutShift | 0 Sec |
| interactive | 7.03 Sec |
| observedSpeedIndex | 2.33 Sec |
| firstContentfulPaint | 0.79 Sec |
| observedNavigationStartTs | 3935868225190 |
| observedTimeOriginTs | 3935868225190 |
| observedFirstContentfulPaintTs | 3935868473010 |
| observedFirstVisualChangeTs | 3935868558190 |
| observedTraceEnd | 7.86 Sec |
| maxPotentialFID | 0.28 Sec |
| observedLargestContentfulPaintAllFramesTs | 3935869630630 |
| observedDomContentLoadedTs | 3935868362864 |
| observedFirstContentfulPaint | 0.25 Sec |
| observedTraceEndTs | 3935876086234 |
| observedLastVisualChangeTs | 3935873625190 |
| observedLargestContentfulPaintTs | 3935869630630 |
| observedLoadTs | 3935871666415 |
| observedFirstPaint | 0.25 Sec |
| observedNavigationStart | 0 Sec |
| observedDomContentLoaded | 0.14 Sec |
| observedLastVisualChange | 5.4 Sec |
| observedFirstMeaningfulPaint | 1.41 Sec |
| observedFirstContentfulPaintAllFrames | 0.25 Sec |
| observedTimeOrigin | 0 Sec |
| observedCumulativeLayoutShiftMainFrame | 0 Sec |
| totalBlockingTime | 0.74 Sec |
| observedCumulativeLayoutShift | 0 Sec |
| observedFirstContentfulPaintAllFramesTs | 3935868473010 |
| cumulativeLayoutShiftMainFrame | 0 Sec |
| observedFirstMeaningfulPaintTs | 3935869630630 |
| observedTotalCumulativeLayoutShift | 0 Sec |
| largestContentfulPaint | 4.49 Sec |
| speedIndex | 3.5 Sec |
